Active Stocks

Fri Nov 07 2025 15:59:09

NTPC share price
326.15 -0.17%

Bharti Airtel share price
2,001.10 -4.46%

Axis Bank share price
1,223.25 -0.43%

Eternal share price
305.95 0.05%

Tata Steel share price
181.45 2.37%

Business News > Mint Authors > Jessica Jani

Jessica Jani

Correspondent

Jessica is a correspondent at Mint. She writes on everything pharma, healthcare and lifesciences.

ARTICLES BY JESSICA JANI

On a constant currency basis, the revenue growth was 10.8% for the quarter..

Divi’s Labs beats Street, Q2 profit soars 35%

2 min read . 07 Nov 2025

Mounjaro gains weight, tops India’s drug charts with ₹100 crore sales in October

3 min read . 07 Nov 2025

Apollo has started its planned expansion of 1,600 beds over the next 15-18 months with a ₹3,500 crore capital expenditure. (Pixabay)

Specialty care offsets seasonal dip, lifts Apollo Hospitals' Q2 profit 26%

3 min read . 06 Nov 2025

Zydus has also been expanding across other segments, including wellness and medtech. (PTI)

Zydus Lifesciences beats expectations, plans to raise ₹5,000 crore

2 min read . 06 Nov 2025

Nandini Piramal, chairperson, Piramal Pharma. (File Photo)

Piramal Pharma bets on US biopharma funding uptick to lift growth

3 min read . 06 Nov 2025

Sun Pharma Q2 Results: US sales accounted for approximately 30.1% of total consolidated sales of Sun Pharmaceutical Industries.

Sun Pharma beats Street—Q2 net profit up 2.6%, US sales down 4%

3 min read . 05 Nov 2025

The past two years have seen the rise of ventures offering services from personalized supplements to centres with physical therapies. (Pixabay )

What Deepinder Goyal’s longevity bet says about India’s wellness elite

8 min read . 02 Nov 2025

Last year, Cipla’s promoter family also saw a shuffle, amid rumors of a potential stake sale. (REUTERS)

Cipla names Achin Gupta next MD & CEO as Umang Vohra is set to exit

4 min read . 30 Oct 2025

Hospital chains like Apollo, Max Healthcare, and Fortis are implementing previously announced expansion plans. (PTI) (PTI)

Hospitals Q2FY26 preview: Better patient mix to offset seasonal infection dip

2 min read . 27 Oct 2025

Dr Reddy's Lab Pic by Bharath Sai

Dr Reddy’s Q2 revenue beats estimates buoyed by consumer NRT portfolio

2 min read . 24 Oct 2025

First Mounjaro, now Yurpeak: Eli Lilly, Cipla tie up for weight loss drug

2 min read . 23 Oct 2025

Biocon Ltd's biosimilar arm recently announced it will supply insulin glargine pens to US-based non-profit Civica. (istockphoto)

Biocon Biologics eyes expansion in the US insulin market

2 min read . 22 Oct 2025

Pharma sales in India during the second quarter are expected to be have been impacted by the GST rate cuts, as distributors focused on de-stocking inventories with old prices while holding back on new orders. (Pixabay)

Pharma Q2 preview: Steady growth despite US sales pressure, GST rate cuts

3 min read . 21 Oct 2025

The case has reignited debate over balancing intellectual property rights and public health imperatives in India. (Image: Pixabay)

SC refuses to restrain Natco from selling generic version of Roche's Risdiplam

3 min read . 17 Oct 2025

Novo Nordisk’s patent on semaglutide, which it sells as Ozempic and WeGovy, is set to expire in key international markets including India and Canada in March 2026, Photo: Reuters

Weight-loss drugs will fatten contract manufacturers’ profits first, market bets

7 min read . 16 Oct 2025

Supreme Court may hear Roche's plea against Natco on Thursday or Friday. (Image: Pixabay)

Roche moves Supreme Court against Natco over sale of generic Risdiplam in India

3 min read . 14 Oct 2025

Concerns over the act’s dilution, as well as uncertainties over the Trump administration drug policies, cloud the picture. Photo: Pexel

The US Biosecure Act is back. How will Indian contract manufacturers benefit?

4 min read . 13 Oct 2025

Natco Pharma has a long history of challenging innovator patents both in India and overseas. (Image: Pixabay)

Natco’s high-stakes patent challenge strategy explained

5 min read . 11 Oct 2025

delhi high court , 26/05/2015 ; new delhi ; photo:pradeep gaur/mint

Delhi HC allows Natco Pharma to sell generic Risdiplam, rejects Roche plea

5 min read . 09 Oct 2025

Large US-focused Indian drugmakers have turned selective, restricting themselves to small, targetted deals even as they sit on large piles of cash. (AFP)

Pharma deals are surging. But the biggest drugmakers are holding back.

5 min read . 09 Oct 2025